Everand Logo

Welcome to Everand!

  • TIME

    The search for the first COVID-19 treatment

    Apr 17, 2020 5 minutes
    By Alice Park

    WITHIN WEEKS AFTER COVID-19 CASES SPIKED TO ALARMing levels in China, researchers at Gilead in Foster City, Calif., saw an opportunity. A drug the company had developed against Ebola, remdesivir, had shown glimmers of hope in controlling coronaviruses like the one responsible for COVID-19 in the lab. “We knew in the test tube that remdesivir had more activity against coronaviruses like SARS and MERS than against Ebola,” says Dr. Merdad Parsey, chief medical officer of Gilead. After disappointing results in early tests against Ebola, Parsey and his team wondered if remdesivir could turn out to be a better treatment for COVID-19 instead.

    Recently, they were rewarded with the first hopeful signs that their hunch might be correct. An international group of researchers reported that in a small study of 53 patients, 68% benefited from

    You’re reading a preview, subscribe to read more.

    More from TIME

    TIME1 min read
    Behind The Scenes
    Patrick Mahomes, Dua Lipa, and Yulia Navalnaya—seen here, clockwise from above, at their photo shoots—all sat down with TIME to discuss the impact of influence and their plans for the future. Go online to read those interviews and watch video extras,
    TIME9 min read
    Artists
    She moves with a lightness in a heavy world—bold, playful, and self-aware. She is thoughtfully outspoken for the oppressed and displaced. She founded an influential editorial platform, Service95, to cover cultural topics and address humanitarian conc
    TIME4 min read
    A Jumbled Parable With A Glowing Core
    Even when a movie is far from perfect, you can tell when a director has poured his soul into it. Dev Patel’s directorial debut Monkey Man—he’s also the movie’s star—is trying too hard, and for too much. It wants to be a political allegory, a somber s

    Related Books & Audiobooks